Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG38257

H2AC14 Knockout HEK293T Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Kidney

The H2AC14 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population targeting the human H2AC14 gene. H2AC14 encodes a replication-dependent histone H2A variant critical for nucleosome structure and chromatin organization. These cells are derived from HEK293T human embryonic kidney cells, which express SV40 large T antigen and support viral packaging and protein production. H2AC14 is transcriptionally controlled by E2F factors and interacts with FACT and NAP1L1 chaperones; it stabilizes nucleosomes and influences DNA repair. This knockout model facilitates investigation of epigenetic regulation, chromatin dynamics, and cancer biology, employing assays such as ChIP-qPCR, immunofluorescence, and cell cycle analysis.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293T

    Sex of Donor

    Female

    Age

    Fetus

    Derived From Site

    Fetal kidney

    Gene Name

    H2AC14

    Gene Identifier

    NCBI Gene ID 8331

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The H2AC14 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population designed to disrupt the human H2AC14 gene. H2AC14 encodes a replication-dependent core histone H2A variant that is integral to nucleosome formation and chromatin architecture. This polyclonal pool, generated in the HEK293T host cell background, provides a heterogeneous loss-of-function model for investigating the functional impact of H2AC14 loss. The polyclonal format averts clonal artifacts, facilitating the study of allele-level chromatin dynamics. These cells are well suited for applications in epigenetic biology, cancer modeling, and compound screening.

The HEK293T cell line is a human embryonic kidney epithelial line transformed with sheared adenovirus type 5 DNA and stably expressing the SV40 large T antigen. It is widely utilized for transient protein expression, viral packaging, and recombinant protein production due to its high transfection efficiency and rapid growth. Large T antigen expression enables episomal replication of plasmids containing the SV40 origin, making the line ideal for lentiviral and retroviral vector production. In chromatin studies, HEK293T cells exhibit active replication-coupled histone deposition, providing a relevant context for examining H2AC14 function.

H2AC14 is a replication-dependent core histone H2A variant that, with histones H2B, H3, and H4, forms nucleosomes. Its transcription is driven by E2F factors and the Cyclin E/CDK2 kinase complex via the NPAT coactivator at histone locus bodies. H2AC14 directly interacts with the FACT complex and NAP1L1 chaperone during nucleosome assembly and exchange, contributing to nucleosome stability and chromatin compaction. This, in turn, influences global gene expression patterns. Additionally, H2AC14 participates in DNA repair by recruiting repair machinery; its loss may compromise nucleosome stability and chromatin accessibility, thereby altering transcriptional and genomic maintenance programs.

Loss of H2AC14 in HEK293T cells provides a powerful model to probe histone variant functions in a transformed human epithelial line. The high proliferation rate and active DNA replication of HEK293T cells render them sensitive to alterations in histone supply and nucleosome assembly. The polyclonal knockout pool mirrors heterogeneous genetic backgrounds, allowing assessment of dosage effects and paralog compensation. This system is particularly relevant to cancer epigenetics, as histone variant deregulation is common in malignancies. Moreover, the presence of SV40 large T antigen, which interacts with host chromatin modifiers, adds a layer of complexity for studying viral oncoprotein effects on histone dynamics.

Applications include Western blotting to confirm histone expression changes, ChIP-qPCR for histone modifications, and immunofluorescence for chromatin structure analysis. Functional assays encompass cell cycle analysis by flow cytometry, DNA damage assays to measure repair capacity, and nucleosome positioning assays. The polyclonal knockout model also supports high-throughput screening for histone-modifying enzyme inhibitors or synthetic lethal partners. Specific studies may probe the role of H2AC14 in E2F-dependent transcription, FACT-mediated chromatin remodeling, or DNA repair pathway choice. For further information or custom project discussions, please reach out to Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)